The IIDR & DBCAD Announce Funding for Collaborative Projects

Since its establishment in 2007, the Michael G. DeGroote Institute for Infectious Disease Research has been active in providing seed funding for new projects and partnerships focused around the overarching themes of anti-infective innovation, diagnostics, and laboratory and clinical collaboration.

Dedicated to helping eliminate the global threat of antimicrobial resistance, the newly established David Braley Centre for Antibiotic Discovery (DBCAD) has further demonstrated its commitment to fostering scientific collaboration by providing significant seed funding for four milestone-driven projects related to antimicrobial research and discovery.

The purpose of these funding initiatives is to provide support for trainees and operating funds to help members generate preliminary data that will enable them to seek additional funding from other agencies and further amplify the impact of their research.

Following an external review of submitted research proposals, the IIDR and DBCAD are pleased to announce this year’s recipients: